Celldex Therapeutics (CLDX) PT Lowered to $63 at Guggenheim
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $39.94 --0%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja lowered the price target on Celldex Therapeutics (NASDAQ: CLDX) to $63.00 (from $68.00) while maintaining a Buy rating.
You May Also Be Interested In
- Lowe's (LOW) PT Lowered to $275 at Guggenheim
- Travis Perkins (TPK:LN) (TPRKY) PT Raised to GBP6.70 at Stifel
- Walmart (WMT) PT Lowered to $130 at UBS as Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
